Results 231 to 240 of about 77,084 (260)

PARP Inhibitors

2014
Joaquin Mateo, Timothy A. Yap, Johann S. De Bono   +2 more
openaire   +1 more source

PARP and PARP Inhibitor Therapeutics

2013
openaire   +1 more source

The Forefront of Ovarian Cancer Therapy: Update on PARP Inhibitors

Annals of Oncology, 2020
Antonio González-Martín, Nicoletta Colombo, R L Coleman   +2 more
exaly  

Missed Therapeutic and Prevention Opportunities in Women With BRCA-Mutated Epithelial Ovarian Cancer and Their Families Due to Low Referral Rates for Genetic Counseling and BRCA Testing: A Review of the Literature

Ca-A Cancer Journal for Clinicians, 2017
Walter H Gotlieb, Paul J Hoskins
exaly  

BRD4 Inhibition Is Synthetic Lethal With PARP Inhibitors Through the Induction of Homologous Recombination Deficiency

Cancer Cell, 2018
Zhenlin Ju, Jun Yin
exaly  

Elevated CXorf67 Expression in PFA Ependymomas Suppresses DNA Repair and Sensitizes to PARP Inhibitors

Cancer Cell, 2020
Meng Yu, Lin Li, Chen Li
exaly  

Sequential Therapy With PARP and WEE1 Inhibitors Minimizes Toxicity While Maintaining Efficacy

Cancer Cell, 2019
Ken Chen, Zhenlin Ju, Gordon B. Mills
exaly  

POTENT PARP INHIBITORS

2009
PENNING THOMAS D, THOMAS SHEELA A, HAJDUK PHILIP J, SAUER DARYL R, SARRIS KATHY, GIRANDA VINCENT L   +5 more
openaire   +2 more sources

Enhancing the Cytotoxic Effects of PARP Inhibitors With DNA Demethylating Agents – A Potential Therapy for Cancer

Cancer Cell, 2016
Michael M Seidman, Feyruz V Rassool, Pratik K Nagaria   +2 more
exaly  

Pyrazoloquinolones are potent parp inhibitors

2007
PENNING THOMAS D, ZHU GUI-DONG, GANDHI VIRAJKUMAR B, GONG JIANCHUN, GIRANDA VINCENT L   +4 more
openaire   +5 more sources